Chromosome 18q allelic loss and prognosis in stage II and III colon cancer

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 390-395

  Lanza, Giovanni ^a   Matteuzzi, Maurizio ^a   Gafá, Roberta ^a   Orvieto, Enrico ^a   Maestri, Iva ^a   Santini, Alessandra ^b   Del Senno, Laura ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UO Pediatria e Adolescentologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; CHROMOSOME LOSS; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANEUPLOIDY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 18; COLONIC NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENES, P53; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; TIME FACTORS;

EID: 0031827793     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.0.CO;2-9     Document Type: Article

References (21)

1. BECKMANN, M.W., PICARD, F., AN, H.X., VAN ROEYEN, C.R.C., DOMINIK, S.I., MOSNY, D.S., SCHNURCH, H.G., BENDER, H.G. and NIEDERACHER, D., Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Brit. J. Cancer, 73, 1220-1226 (1996).
2. CHO, K.R. and FEARON, E.R., DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? Curr. Opin. Genet. Develop., 5, 72-78 (1995).
3. DEL SENNO, L., MAESTRI, I., PIVA, R., BIANCHINI, E., Rossi, R. and DEGLI UBERTI, E., A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy. Oncogene,6, 1895-1898 (1991).
4. EPPERT, K. and 12 OTHERS, MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543-552 (1996).
5. HOULSTON, R.S. and TOMLINSON, I.P.M., Genetic prognostic markers in colorectal cancer. J. Clin. Pathol. Mol. Pathol., 50, 281-288 (1997).
6. IINO, H., FUKAYAMA, M., MAEDA, Y., KOIKE, M., MORI, T., TAKAHASHI, T., KIKUCHI-YANOSHITA, R., MIYAK, M., MIZUNO, S. and WATANABE, S., Molecular genetics for clinical management of colorectal carcinoma: 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer, 73, 1324-1331 (1994).
7. ITOH, F., HINODA, Y., OHE, M., OHE, Y., BAN, T., ENDO, T., IMAI, K. and YACHI, A., Decreased expression of DCC mRNA in human colorectal cancers. Int. J. Cancer, 53, 260-263 (1993).
8. JEN, J., KIM, H., PIANTADOSI, S., LIU, Z-F., LEVITT, R.C., SISTONEN, P., KINZLER, K.W., VOGELSTEIN, B. and HAMILTON, S.R., Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 331, 213-221 (1994).
9. KERN, S.E., FEARON, E.R., TERSMETTE, K.W.F., ENTERLINE, J.P., LEPPERT, M., NAKAMURA, Y., WHITE, R., VOGELSTEIN, B. and HAMILTON, S.R., Allelic loss in colorectal carcinoma. J. Amer. Med. Ass., 261, 3099-3103 (1989).
10. LANZA, G., GAFÁ, R., SANTINI, A., MAESTRI, I., DUBINI, A., GILLI, G. and CAVAZZINI, L., Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer, 82, 49-59 (1998).
11. LANZA, G. JR., MAESTRI, I., DUBINI, A., GAFÁ, R., SANTINI, A., FERRETTI, S. and CAVAZZINI, L., p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern, and short-term survival. Amer. J. Clin. Pathol., 105, 604-612 (1996).
12. LEE, E. and DESU, M., A computer program for comparing K samples with right censored data. Comput. Programs Biomed., 2, 315-320 (1972).
13. LIU, B. and 12 OTHERS, Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature (Genet.), 9, 48-55 (1995).
14. LOTHE, R.A. and 15 OTHERS, Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res., 53, 5849-5852 (1993).
15. MOERTEL, C.G., FLEMING, T.R., MACDONALD, J.S., HALLER, D.G., LAURIE, J.A., TANGEN, C.M., UNGERLEIDER, J.S., EMERSON, W.A., TORMEY, D.C., CLICK, J.H., VEEDER, M.H. and MAILLIARD, J.A., Intergroup study of fiuorouracil plus levamisole as adjuvant therapy for stage 11/Dukes' B2 colon cancer. J. Clin. Oncol., 13, 2936-2943 (1995).
16. OOKAWA, K., SAKAMOTO, M., HIROHASHI, S., YOSHIDA, Y., SUGIMURA, T., TERADA, M. and YOKOTA, J., Concordant p53 and DCC alterations and allelic losses on chromosome 13q and 14q associated with liver metastases of colorectal carcinoma. Int. J. Cancer, 53, 382-387 (1993).
17. RIGGINS, G.J., THIAGALINGAM, S., ROZENBLUM, E., WEINSTEIN, C.L., KERN, S.E., HAMILTON, S.R., WILLSON, J.K.V., MARKOWITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Mad-related genes in the human. Nature (Genet.), 13, 347-349 (1996).
18. SHIBATA, D., REALE, M.A., LAVIN, P., SILVERMAN, M., FEARON, E.R., STEELE, G., JESSUP, J.M., LODA, M. and SUMMERHAYES, I.C., The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med., 335, 1727-1732 (1996).
19. TAKAGI, Y., KOHMURA, H., FUTAMURA, M., KIDA, H., TANEMURA, H., SHIMOKAWA, K., and SAJI, S., Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology, 111, 1369-1372 (1996).
20. THIAGALINGAM, S., LENGAUER, C., LEACH, F.S., SCHUTTE, M., HAHN, S.A., OVERHAUSER, J., WILLSON, J.K.V., MARKOWITZ, S., HAMILTON, S.R., KERN, S.E., KINZLER, K.W. and VOGELSTEIN, B., Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature (Genet.), 13, 343-346 (1996).
21. THIBODEAU, S.N., BREN, G. and SCHAID, D., Microsatellite instability in cancer of the proximal colon. Science, 260, 816-819 (1993).